Serum miR-128 Serves as a Potential Diagnostic Biomarker for Alzheimer’s Disease [Corrigendum]
Open Access
- 1 February 2021
- journal article
- correction
- Published by Taylor & Francis Ltd in Neuropsychiatric Disease and Treatment
- Vol. ume 17, 513-514
- https://doi.org/10.2147/ndt.s306151
Abstract
Serum miR-128 Serves as a Potential Diagnostic Biomarker for Alzheimer’s Disease [Corrigendum]Keywords
This publication has 1 reference indexed in Scilit:
- Serum miR-128 Serves as a Potential Diagnostic Biomarker for Alzheimer’s DiseaseNeuropsychiatric Disease and Treatment, 2021